SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001104659-23-091249
Filing Date
2023-08-14
Accepted
2023-08-14 15:21:03
Documents
4

Document Format Files

Seq Description Document Type Size
1 424B3 tm2322856-2_424b3.htm 424B3 237875
2 GRAPHIC tm2322856d1_s1img01.jpg GRAPHIC 2219
3 GRAPHIC tm2322856d1_s1img02.jpg GRAPHIC 24756
4 GRAPHIC tm2322856d1_s1img03.jpg GRAPHIC 2326
  Complete submission text file 0001104659-23-091249.txt   279839
Mailing Address 600 MADISON AVENUE, SUITE 1601 NEW YORK NY 10022-1737
Business Address 600 MADISON AVENUE, SUITE 1601 NEW YORK NY 10022-1737 302 355-0650
iBio, Inc. (Filer) CIK: 0001420720 (see all company filings)

IRS No.: 262797813 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 424B3 | Act: 33 | File No.: 333-273749 | Film No.: 231169115
SIC: 2834 Pharmaceutical Preparations